vs
ARTIVION, INC.（AORT）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
Ranger Energy Services, Inc.的季度营收约是ARTIVION, INC.的1.2倍（$142.2M vs $116.0M），Ranger Energy Services, Inc.净利率更高（2.3% vs 2.1%，领先0.2%），ARTIVION, INC.同比增速更快（19.2% vs -0.6%），Ranger Energy Services, Inc.自由现金流更多（$17.1M vs $-7.9M），过去两年ARTIVION, INC.的营收复合增速更高（9.1% vs 1.9%）
Artivion, Inc.是一家专注于心血管移植领域的医疗企业，主要供应经深低温冷冻保存的人体组织，同时研发各类医疗器械。旗下核心产品包括经过特殊处理、去除多余细胞物质与抗原的人体心脏瓣膜，以及BioGlue手术粘合剂，可为临床诊疗提供专业支持。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
AORT vs RNGR — 直观对比
营收规模更大
RNGR
是对方的1.2倍
$116.0M
营收增速更快
AORT
高出19.8%
-0.6%
净利率更高
RNGR
高出0.2%
2.1%
自由现金流更多
RNGR
多$25.0M
$-7.9M
两年增速更快
AORT
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $116.0M | $142.2M |
| 净利润 | $2.4M | $3.2M |
| 毛利率 | 63.1% | — |
| 营业利润率 | 9.2% | 2.3% |
| 净利率 | 2.1% | 2.3% |
| 营收同比 | 19.2% | -0.6% |
| 净利润同比 | 114.7% | -44.8% |
| 每股收益（稀释后） | $0.06 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AORTRNGR
| Q4 25 | $116.0M | $142.2M | ||
| Q3 25 | $113.4M | $128.9M | ||
| Q2 25 | $113.0M | $140.6M | ||
| Q1 25 | $99.0M | $135.2M | ||
| Q4 24 | $97.3M | $143.1M | ||
| Q3 24 | $95.8M | $153.0M | ||
| Q2 24 | $98.0M | $138.1M | ||
| Q1 24 | $97.4M | $136.9M |
净利润AORTRNGR
| Q4 25 | $2.4M | $3.2M | ||
| Q3 25 | $6.5M | $1.2M | ||
| Q2 25 | $1.3M | $7.3M | ||
| Q1 25 | $-505.0K | $600.0K | ||
| Q4 24 | $-16.5M | $5.8M | ||
| Q3 24 | $-2.3M | $8.7M | ||
| Q2 24 | $-2.1M | $4.7M | ||
| Q1 24 | $7.5M | $-800.0K |
毛利率AORTRNGR
| Q4 25 | 63.1% | — | ||
| Q3 25 | 65.6% | — | ||
| Q2 25 | 64.7% | — | ||
| Q1 25 | 64.2% | — | ||
| Q4 24 | 63.2% | — | ||
| Q3 24 | 63.7% | — | ||
| Q2 24 | 64.6% | — | ||
| Q1 24 | 64.6% | — |
营业利润率AORTRNGR
| Q4 25 | 9.2% | 2.3% | ||
| Q3 25 | 11.1% | 2.0% | ||
| Q2 25 | 7.4% | 6.1% | ||
| Q1 25 | 2.2% | 0.7% | ||
| Q4 24 | 2.7% | 6.2% | ||
| Q3 24 | 4.6% | 8.4% | ||
| Q2 24 | 6.6% | 5.3% | ||
| Q1 24 | 26.0% | -0.4% |
净利率AORTRNGR
| Q4 25 | 2.1% | 2.3% | ||
| Q3 25 | 5.7% | 0.9% | ||
| Q2 25 | 1.2% | 5.2% | ||
| Q1 25 | -0.5% | 0.4% | ||
| Q4 24 | -16.9% | 4.1% | ||
| Q3 24 | -2.4% | 5.7% | ||
| Q2 24 | -2.2% | 3.4% | ||
| Q1 24 | 7.7% | -0.6% |
每股收益（稀释后）AORTRNGR
| Q4 25 | $0.06 | $0.14 | ||
| Q3 25 | $0.13 | $0.05 | ||
| Q2 25 | $0.03 | $0.32 | ||
| Q1 25 | $-0.01 | $0.03 | ||
| Q4 24 | $-0.40 | $0.24 | ||
| Q3 24 | $-0.05 | $0.39 | ||
| Q2 24 | $-0.05 | $0.21 | ||
| Q1 24 | $0.18 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.9M | $10.3M |
| 总债务越低越好 | $215.1M | — |
| 股东权益账面价值 | $448.2M | $300.1M |
| 总资产 | $884.8M | $419.3M |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势，按日历期对齐
现金及短期投资AORTRNGR
| Q4 25 | $64.9M | $10.3M | ||
| Q3 25 | $73.4M | $45.2M | ||
| Q2 25 | $53.5M | $48.9M | ||
| Q1 25 | $37.7M | $40.3M | ||
| Q4 24 | $53.5M | $40.9M | ||
| Q3 24 | $56.2M | $14.8M | ||
| Q2 24 | $55.0M | $8.7M | ||
| Q1 24 | $51.1M | $11.1M |
总债务AORTRNGR
| Q4 25 | $215.1M | — | ||
| Q3 25 | $214.9M | — | ||
| Q2 25 | $215.6M | — | ||
| Q1 25 | $314.7M | — | ||
| Q4 24 | $314.3M | $0 | ||
| Q3 24 | $314.0M | $0 | ||
| Q2 24 | $313.6M | $0 | ||
| Q1 24 | $313.3M | $0 |
股东权益AORTRNGR
| Q4 25 | $448.2M | $300.1M | ||
| Q3 25 | $438.7M | $270.0M | ||
| Q2 25 | $419.9M | $276.9M | ||
| Q1 25 | $294.3M | $272.6M | ||
| Q4 24 | $276.2M | $273.8M | ||
| Q3 24 | $304.7M | $267.6M | ||
| Q2 24 | $295.1M | $260.5M | ||
| Q1 24 | $295.0M | $261.7M |
总资产AORTRNGR
| Q4 25 | $884.8M | $419.3M | ||
| Q3 25 | $857.7M | $372.8M | ||
| Q2 25 | $838.4M | $381.7M | ||
| Q1 25 | $791.2M | $376.5M | ||
| Q4 24 | $789.1M | $381.6M | ||
| Q3 24 | $803.1M | $373.9M | ||
| Q2 24 | $789.5M | $359.6M | ||
| Q1 24 | $784.0M | $355.5M |
负债/权益比AORTRNGR
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.49× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 1.14× | 0.00× | ||
| Q3 24 | 1.03× | 0.00× | ||
| Q2 24 | 1.06× | 0.00× | ||
| Q1 24 | 1.06× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.6M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $-7.9M | $17.1M |
| 自由现金流率自由现金流/营收 | -6.9% | 12.0% |
| 资本支出强度资本支出/营收 | 23.7% | 4.9% |
| 现金转化率经营现金流/净利润 | 8.06× | 7.53× |
| 过去12个月自由现金流最近4个季度 | $839.0K | $42.9M |
8季度趋势，按日历期对齐
经营现金流AORTRNGR
| Q4 25 | $19.6M | $24.1M | ||
| Q3 25 | $22.3M | $13.6M | ||
| Q2 25 | $15.0M | $20.7M | ||
| Q1 25 | $-17.0M | $10.6M | ||
| Q4 24 | $10.1M | $32.7M | ||
| Q3 24 | $11.5M | $17.7M | ||
| Q2 24 | $6.1M | $22.1M | ||
| Q1 24 | $-5.5M | $12.0M |
自由现金流AORTRNGR
| Q4 25 | $-7.9M | $17.1M | ||
| Q3 25 | $17.7M | $8.0M | ||
| Q2 25 | $11.7M | $14.4M | ||
| Q1 25 | $-20.6M | $3.4M | ||
| Q4 24 | $8.7M | $27.3M | ||
| Q3 24 | $7.8M | $10.8M | ||
| Q2 24 | $3.6M | $6.8M | ||
| Q1 24 | $-9.1M | $5.5M |
自由现金流率AORTRNGR
| Q4 25 | -6.9% | 12.0% | ||
| Q3 25 | 15.6% | 6.2% | ||
| Q2 25 | 10.4% | 10.2% | ||
| Q1 25 | -20.8% | 2.5% | ||
| Q4 24 | 9.0% | 19.1% | ||
| Q3 24 | 8.2% | 7.1% | ||
| Q2 24 | 3.7% | 4.9% | ||
| Q1 24 | -9.3% | 4.0% |
资本支出强度AORTRNGR
| Q4 25 | 23.7% | 4.9% | ||
| Q3 25 | 4.1% | 4.3% | ||
| Q2 25 | 2.9% | 4.5% | ||
| Q1 25 | 3.7% | 5.3% | ||
| Q4 24 | 1.5% | 3.8% | ||
| Q3 24 | 3.8% | 4.5% | ||
| Q2 24 | 2.6% | 11.1% | ||
| Q1 24 | 3.7% | 4.7% |
现金转化率AORTRNGR
| Q4 25 | 8.06× | 7.53× | ||
| Q3 25 | 3.42× | 11.33× | ||
| Q2 25 | 11.16× | 2.84× | ||
| Q1 25 | — | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 4.70× | ||
| Q1 24 | -0.73× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AORT
| Aortic Stent Grafts | $43.3M | 37% |
| On X | $27.8M | 24% |
| Preservation Services | $24.1M | 21% |
| Surgical Sealants | $20.3M | 18% |
| Other Products | $463.0K | 0% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
